How much cash does Achieve Life Sciences generate?

Achieve Life Sciences (ACHV) generated -$45.3M in operating cash flow over the trailing twelve months.

What is Achieve Life Sciences's free cash flow?

After $3.0K of capital expenditures, Achieve Life Sciences's free cash flow was -$49.5M over the trailing twelve months, down 269.2% year over year.

Where does Achieve Life Sciences's cash flow data come from?

Every line is extracted from Achieve Life Sciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Achieve Life Sciences ACHV Cash Flow Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Net income	-$51.99M+4.9%	-$54.65M-4.4%	-$52.35M-3.8%	-$50.42M-9.2%	-$46.16M-15.9%
Depreciation and amortization	$223K-2.2%	$228K-0.4%	$229K-1.3%	$232K-0.9%	$234K+2.2%
Stock-based compensation	$5.84M-33.3%	$8.76M+0.7%	$8.7M+13.0%	$7.7M+22.9%	$6.27M+17.7%
Amortization of debt issuance costs	$50K-3.8%	$52K-5.5%	$55K—	——	——
Change in accounts payable	——	——	——	$668K-48.0%	$1.28M-3.6%
Change in accrued liabilities	——	——	——	——	$99K-86.2%
Change in other assets	——	——	——	——	——
Loss on extinguishment of debt	——	——	——	——	——
Change in fair value of contingent consideration	$32K-92.2%	$408K-45.2%	$744K+6.3%	$700K+6.1%	$660K+6.3%
Net cash from operating activities	-$45.31M+8.4%	-$49.47M-21.6%	-$40.68M-2.4%	-$39.72M-11.7%	-$35.57M-19.5%
Capital expenditures	——	$3K—	——	——	——
Net cash from investing activities	——	——	——	$7.27M+250%	-$4.83M+77.6%
Proceeds from issuance of debt	——	——	——	——	——
Repayments of debt	——	——	——	——	——
Proceeds from issuance of common stock	——	$0-100%	$44.5K-50.0%	$89K-33.3%	$133.5K-25.0%
Taxes paid for net share settlement	——	$0-100%	$28.5K-50.0%	$57K-33.3%	$85.5K-25.0%
Net cash from financing activities	——	——	——	——	——
Effect of exchange rate changes on cash	——	——	——	——	——
Net increase (decrease) in cash	——	——	——	——	——
Amortization expense related to capitalized debt issuance costs	$50K-3.8%	$52K-5.5%	$55K—	——	——
Contingent consideration fair value adjustments	$32K-92.2%	$408K-45.2%	$744K+6.3%	$700K+6.1%	$660K+6.3%
Accrued compensation and employee benefits	——	——	——	——	$99K-86.2%
Increase Decrease In Lease Obligations	——	——	——	——	——
Payments On Loss On Disposal Of Property And Equipment	——	$1K—	——	——	——
Proceeds From Realized Gain On Investments	——	$4K—	——	——	——
Proceeds From Exercise Of Overallotment Option Net Of Issuance Costs	——	$4M—	——	——	——
Proceeds From Warrant Exercises	——	——	——	——	——
Receipt Of SVB Convertible Term Loan Second Tranche	——	$5M—	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Achieve Life Sciences generate?: Achieve Life Sciences (ACHV) generated -$45.3M in operating cash flow over the trailing twelve months.
What is Achieve Life Sciences's free cash flow?: After $3.0K of capital expenditures, Achieve Life Sciences's free cash flow was -$49.5M over the trailing twelve months, down 269.2% year over year.
Where does Achieve Life Sciences's cash flow data come from?: Every line is extracted from Achieve Life Sciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.